1 week to go until #ACNAP26 ๐ค
Meet our amazing #ACNAP26 Social Media Ambassadors
We're excited to introduce the team who will be bringing you live congress updates, key takeaways, and real-time insights from the world of cardiovascular nursing and allied professions.
๐
.@escardio does not endorse the unfortunate personal post by one of its social media ambassadors. Diego Araiza has publicly apologised and will no longer be an ambassador for the society, as his message infringed ESC social media guidelines.
#ADVOR trial: acetazolamide added to intravenous loop diuretics decreases congestion within 3 days in patients with acute decompensated #heartfailure.
#ESCCongress
#Semaglutide improves heart failure-related symptoms and physical function and results in greater weight loss compared with placebo in patients with #HFpEF and #obesity โฌ๏ธ
#ESCCongress STEP-HFpEF trial
Share your technology or innovation with the cardiac community.
Two great opportunities to present your digital health solutions during ESC Congress / ESC Digital Summit 2019. Submit by 28 June bit.ly/2weJu5K
#TIME trial: randomised trial in more than 21,000 patients with high blood pressure has concluded that protection against heart attack, stroke and vascular death is not affected by whether antihypertensive medications are taken in the morning or evening.
#ESCCongress
#REVIVED trial: Percutaneous coronary intervention does not reduce all-cause mortality or #heartfailure hospitalisation in patients with severe left ventricular dysfunction and extensive #coronary artery disease.
#ESCCongress